Using the same STAT3 conditional deletion in the T-cell lineage, they demonstrated that STAT3-/- CD8+ T cells had increased IFNγ production and increased CXCR3 expression in subcutaneous melanoma (B16) and lung carcinoma (3LL) models. The gene discussed is STAT3; the disease is melanoma.